News source: Business Wire Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to... [read full story]
|
RELATED
|
|
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The...
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta...
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office has issued U.S.
REHOVOT, Israel & PHILADELPHIA - Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S....
Kenneth A. Berlin has been appointed president and chief executive officer, Rosetta Genomics, Ltd. , and has been recommended to serve on the company’s board of directors. Mr. Berlinpreviously served as worldwide general...
Rumor has it that a certain KB, previously Managing Director at Veridex until he got fired, has just been appointed CEO of Rosetta Genomics. The arrogant fool nearly ruined Veridex, and now he's going to do the same to Rosetta...
News source: Business Wire Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer,...
Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive read more
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive...
Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective...
